HPV-Associated Oropharyngeal Cancer Rates by State
Rates are per 100,000 and age-adjusted to the 2000 U.S. Standard Population (19 age groups — Census P25-1130) standard.
Data are from population-based cancer registries participating in CDC’s National Program of Cancer Registries or the National Cancer Institute’s Surveillance, Epidemiology and End Results Program, include all states meeting United States Cancer Statistics publication criteria for all years 2008–2012, and cover about 99% of the U.S. population.
‡Rates were suppressed if the data did not meet USCS publication criteria or if there were fewer than 16 cases.
HPV-associated cancers were defined as cancers at specific anatomic sites and with specific cellular types in which HPV DNA frequently is found. All cancers were confirmed histologically. Oropharyngeal (ICD-O-3 site codes C01.9, C02.4, C02.8, C05.0, C05.1, C05.2, C05.8, C05.9, C09.0, C09.1, C09.8, C09.9, C10.0, C10.1, C10.2, C10.3, C10.4, C10.8, C10.9, C14.0, C14.2 and C14.8) cancers were limited to squamous cell carcinomas (ICD-O-3 histology codes 8050–8084, 8120–8131).